poorly differentiated

poorly differentiated

Oncology adjective Referring to a malignancy in which the malignant cells bear minimal resemblance to the cell from which they arose. Cf Well-differentiated.
References in periodicals archive ?
In a study of 52 cases of gastric carcinoma in Indian population, HER2/neu3+ positivity, like our study, was commonest in moderately differentiated tumours (53%), followed by poorly differentiated adenocarcinoma (39%).16
Histological examination revealed the presence of a malignant intestinal epithelium, with unquestionable invasive areas of poorly differentiated mucinous adenocarcinoma.
Their topics include, diffuse and nodular hyperplasia, follicular adenoma and H'rthle cell (oncocytic) adenoma, poorly differentiated carcinoma, rare primary thyroid epithelial tumors, and principles of molecular diagnostics in thyroid samples.
(28) Invasive carcinomas were graded as well, as intermediate or poorly differentiated, using the Nottingham grading system.
This grading system in practice helps in connection between the scores of malignancy and prognosis of tumour11 Grading system is categorized as highly, moderately and poorly differentiated. Broders classification 1920 a quantitative grading system for cancer.12
Regarding the alterations of the molecular markers of prostate-related disorders, the study employed SPF, previously introduced in prognosis for variety of malignancies.20 SPF is able to discriminate between PCa and benign prostate lesions,21 as well as in between poorly differentiated carcinomas compared to well differentiated tissues.
When conducting this study, TSA, a potent and reversible class I and II HDAC inhibitor, was applied to poorly differentiated PANC-1 cells.
Tenders are invited for Supply of Chemical MKN45 General Cells Profile adenocarcinoma poorly differentiated
Poorly differentiated squamous 2 1.43 cell carcinoma c.
Out of 55 cases, 32 cases (58.2%) were well differentiated, 18 cases (32.7%) were moderately differentiated and 5 cases (9.1%) were poorly differentiated. Forty-eight cases of hepatocellular carcinoma (87.3%) showed positivity for glypican-3 while 7 cases (12.7%) were negative.
The biopsy was suggestive of poorly differentiated adenocarcinoma.
The WHO grading system was applied to classify tumors into well, moderately or poorly differentiated. Statistical Analysis: Variables described as mean +- standard deviation.